These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24900663)

  • 1. Immune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses.
    Putta MR; Bhagat L; Wang D; Zhu FG; Kandimalla ER; Agrawal S
    ACS Med Chem Lett; 2013 Feb; 4(2):302-5. PubMed ID: 24900663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9.
    Yu D; Wang D; Zhu FG; Bhagat L; Dai M; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Aug; 52(16):5108-14. PubMed ID: 19650625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation.
    Jurk M; Vollmer J
    BioDrugs; 2007; 21(6):387-401. PubMed ID: 18020622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics.
    Wang H; Rayburn E; Zhang R
    Curr Pharm Des; 2005; 11(22):2889-907. PubMed ID: 16101444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses.
    Yeh DW; Lai CY; Liu YL; Lu CH; Tseng PH; Yuh CH; Yu GY; Liu SJ; Leng CH; Chuang TH
    Sci Rep; 2017 Dec; 7(1):17297. PubMed ID: 29229937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
    Fehér K
    Curr Protein Pept Sci; 2019; 20(11):1060-1068. PubMed ID: 31470785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CpG oligodeoxynucleotide-mediated immune stimulation by locked nucleic acid (LNA).
    Vollmer J; Jepsen JS; Uhlmann E; Schetter C; Jurk M; Wader T; Wüllner M; Krieg AM
    Oligonucleotides; 2004; 14(1):23-31. PubMed ID: 15104893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
    Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
    J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal sequence requirements for oligodeoxyribonucleotides activating human TLR9.
    Pohar J; Kužnik Krajnik A; Jerala R; Benčina M
    J Immunol; 2015 Apr; 194(8):3901-8. PubMed ID: 25780037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nature and length of linker incorporated in agonists on toll-like receptor 9-mediated immune responses.
    Putta MR; Yu D; Bhagat L; Wang D; Zhu FG; Kandimalla ER
    J Med Chem; 2010 May; 53(9):3730-8. PubMed ID: 20361743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide conjugation at the 5'-end of oligodeoxynucleotides abrogates toll-like receptor 9-mediated immune stimulatory activity.
    Putta MR; Zhu FG; Wang D; Bhagat L; Dai M; Kandimalla ER; Agrawal S
    Bioconjug Chem; 2010 Jan; 21(1):39-45. PubMed ID: 20020767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of potent immunostimulatory CpG-ODNs widely distributed in bacterial genomes.
    Liu J; Wei Y; Lu Y; Li Y; Chen Q; Li Y
    J Microbiol; 2020 Feb; 58(2):153-162. PubMed ID: 31872374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9.
    Pohar J; Lainšček D; Kunšek A; Cajnko MM; Jerala R; Benčina M
    Sci Rep; 2017 Nov; 7(1):14598. PubMed ID: 29097808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.
    Jurk M; Kritzler A; Debelak H; Vollmer J; Krieg AM; Uhlmann E
    ChemMedChem; 2006 Sep; 1(9):1007-14. PubMed ID: 16952134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists.
    Tu ATT; Hoshi K; Ikebukuro K; Hanagata N; Yamazaki T
    Biomacromolecules; 2020 Sep; 21(9):3644-3657. PubMed ID: 32857497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.
    Schetter C; Vollmer J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):204-10. PubMed ID: 15603254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators.
    Nigar S; Shimosato T
    Front Nutr; 2019; 6():140. PubMed ID: 31508424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C; An M; Li M; Liu H
    Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.